Company: TELO
Filing Date: 2025-05-21
Form Type: 8-K
Source: 0001641172-25-011938
Chunk: 1

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-05-21
Form: 8-K
Item: Item 3.02
Chunk 1
---
 graduate studies.

Mr.
Weichselbaum earned his MBA in Finance from New York University and is a Certified Public Accountant licensed in the State of New York.
His deep financial acumen, combined with extensive experience in investor relations, capital formation, and M& A, makes him a vital
member of the executive leadership at Telomir Pharmaceuticals, Inc.

There
is no arrangement or understanding between Mr. Weichselbaum and any other persons pursuant to which Mr. Weichselbaum was appointed to
his position. There are no family relationships between Mr. Weichselbaum and any of the Company’s officers or directors. Other
than as described below, there are no other transactions to which the Company or any of its subsidiaries is a party in which Mr. Weichselbaum
has a material interest subject to disclosure under Item 404(a) of Regulation S-K.

In
connection with Alan Weichselbaum’s appointment as the Company’s Chief Financial Officer, on May 15, 2025, the Company entered
into an Employment Agreement (the “ Employment Agreement”) with Mr. Weichselbaum to serve as chief financial officer of the
Company beginning on May 19, 2025 (the “ Start Date”). Under the Employment Agreement, Mr. Weichselbaum will receive an annual
salary of $60,000 and is also eligible to receive up to 50,000 option to purchase shares of the Company’s Common Stock (the “ Options”).
Twenty-five thousand (25,000) of the Options will vest six (6) months following the Start Date, and twenty-five thousand (25,000) of
the Option will vest twelve (12) months following the Start Date, subject to Mr. Weichselbaum’s continued employment by the Company
on each such vesting date. Mr. Weichselbaum’s employment with the Company is on an at-will basis, and either he or the Company
may terminate the Employment Agreement at any time and for any reason.

The
foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the
full text of such agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item
9.01. Financial Statements and Exhibits.

  Exhibit      Exhibit                                                                                                 
      No.      Description                                                                                             
     10.1      Employment Agreement, dated May 15,